Monthly Archives: October 2018

2018 Ambulatory Surgery Center (ASC) Market: Projected to Increase from $36 Billion in 2018, to $40 Billion by 2020 – ResearchAndMarkets.com

October 11, 2018 DUBLIN--(BUSINESS WIRE)--The "2018 Ambulatory Surgery Center Market" report has been added to ResearchAndMarkets.com's offering. The ambulatory surgery center (ASC) market was estimated to reach $36 billion in 2018, and is projected to increase to $40 billion by 2020. Drivers for revenue growth are: lower outpatient surgery costs in ASCs compared to other settings, improved safety driven

By |2018-10-11T18:25:15+00:00October 11th, 2018|Financial|
Read More

TransEnterix Receives FDA 510(k) Clearance for 3mm Diameter Instruments

October 11, 2018 RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that the Company received FDA 510(k) clearance for 3 millimeter diameter instruments, as well as additional 5 millimeter Senhance System instruments. The

By |2018-10-11T17:17:08+00:00October 11th, 2018|Regulatory, Robotics|
Read More

Medacta International Adds Mpact 3D Metal Implants and Augments to Mpact System for Primary Hip Replacement and Revision Surgeries

October 11, 2018 CASTEL SAN PIETRO, Switzerland--(BUSINESS WIRE)--Medacta® International, the privately owned, global leader in innovative joint replacement and spinal technologies, today announced it has received clearance from the U.S. Food and Drug Administration (FDA) for the Mpact 3D Metal™ Implants and Augments 3D Metal as enhancements to its Mpact® System for primary to complex hip revision

By |2018-10-11T16:43:36+00:00October 11th, 2018|Recon, Regulatory, Top Stories|
Read More

Catalyst OrthoScience Introduces 3-Peg Glenoid To Its Catalyst CSR™ Total Shoulder System

October 11, 2018 NAPLES, Fla.--(BUSINESS WIRE)--Catalyst OrthoScience Inc. (Catalyst), a cutting-edge medical device company focused on the upper extremity orthopedics market, today introduced the patent pending 3-Peg Glenoid implant to its innovative Catalyst CSR™ Total Shoulder System. The new implant was unveiled at the American Shoulder and Elbow Surgeons (ASES) 2018 Annual Meeting in Chicago, Ill. Loosening of

By |2018-10-11T16:15:06+00:00October 11th, 2018|Recon|
Read More

Medicrea Third Quarter 2018 Sales

October 11, 2018 LYON, France and NEW YORK--(BUSINESS WIRE)--The Medicrea Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market – MRNTY & MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD™ ASI (Adaptive Spine Intelligence) proprietary software platform, services and technologies, publishes its

By |2018-10-11T15:32:54+00:00October 11th, 2018|Financial|
Read More

K2M Receives FDA Clearance Including Surgical Guidance that Enhances MESA® Platform Using Patient-Specific Rods & Rails

LEESBURG, Va., Oct. 10, 2018 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (NASDAQ:KTWO) (the "Company" or "K2M"), a global leader of complex spine and minimally invasive solutions focused on achieving three-dimensional Total Body Balance™, today announced at the Scoliosis Research Society 53rd Annual Meeting & Course, in Bologna, Italy a U.S. Food and Drug Administration (FDA) 510(k) clearance that

By |2018-10-10T22:30:27+00:00October 10th, 2018|Regulatory|
Read More

Wright Medical Group N.V. Completes Acquisition of Cartiva, Inc.

AMSTERDAM, The Netherlands, Oct. 10, 2018 (GLOBE NEWSWIRE) -- Wright Medical Group N.V. (NASDAQ:WMGI) today announced it has completed its acquisition of Cartiva, Inc. (Cartiva), an orthopaedic medical device company focused on treatment of osteoarthritis of the great toe.  The transaction adds a differentiated PMA-approved technology for a high-volume foot and ankle procedure and further

By |2018-10-10T22:09:28+00:00October 10th, 2018|Financial|
Read More

EOS imaging Showcases hipEOS at the International Society for Technology in Arthroplasty (ISTA) in London

October 10, 2018 PARIS--(BUSINESS WIRE)--Regulatory News: EOS imaging (Euronext, FR0011191766 – EOSI - Eligible PEA - SME), the pioneer of 2D/3D imaging and data solutions for orthopedics, will demonstrate its online hipEOS 3D surgical planning software at its booth during the International Society for Technology in Arthroplasty’s (ISTA) 31st Annual Congress, being held October 10-13 in

By |2018-10-10T19:41:19+00:00October 10th, 2018|Recon|
Read More

SpineEX® Announces FDA Clearance of Sagittae® Lateral Lumbar Interbody Fusion Devices

FREMONT, Calif., Oct. 10, 2018 /PRNewswire/ -- SpineEX, Inc., a medical device company that aims to provide innovative and minimally invasive implants, high-value disposables and instrumentation for spinal fusion surgeries, announced today it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Sagittae lateral lumbar interbody fusion (LLIF) device. The LLIF procedure

By |2018-10-10T16:51:09+00:00October 10th, 2018|Regulatory, Spine, Top Stories|
Read More

CVS Health Acquisition of Aetna Moving Forward on Agreement with U.S. Department of Justice

WOONSOCKET, R.I., Oct. 10, 2018 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced that it has entered into an agreement with the U.S. Department of Justice (DOJ) that allows it to proceed with its proposed acquisition of Aetna (NYSE: AET). DOJ clearance is a key milestone toward finalizing the transaction, which is also subject to state regulatory approvals, many of

By |2018-10-10T16:27:33+00:00October 10th, 2018|Regulatory|
Read More
Odysseus Medical Solutions 2018
RssEmail